Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absent

• Published in: Cardiovascular research 2016-09, Vol.111 (4), p.410-421
• Main Authors: Takanari, Hiroki, Bourgonje, Vincent J A, Fontes, Magda S C, Raaijmakers, Antonia J A, Driessen, Helen, Jansen, John A, van der Nagel, Roel, Kok, Bart, van Stuijvenberg, Leonie, Boulaksil, Mohamed, Takemoto, Yoshio, Yamazaki, Masatoshi, Tsuji, Yukiomi, Honjo, Haruo, Kamiya, Kaichiro, Kodama, Itsuo, Anderson, Mark E, van der Heyden, Marcel A G, van Rijen, Harold V M, van Veen, Toon A B, Vos, Marc A
• Format: Article
• Language: English
• Subjects: Animals; Anti-Arrhythmia Agents - metabolism; Anti-Arrhythmia Agents - pharmacology; Arrhythmias, Cardiac - metabolism; Calcium-Calmodulin-Dependent Protein Kinase Type 2 - metabolism; Calmodulin - metabolism; Cell Communication - drug effects; Connexin 43 - metabolism; Dogs; Gap Junctions - metabolism; Heart - physiopathology; Heart Conduction System - drug effects; Heart Conduction System - metabolism; Mice; Models, Animal; Myocardium - metabolism; ORIGINAL ARTICLES; Rabbits; Rats
• ISSN: 0008-6363; 1755-3245
• DOI: 10.1093/cvr/cvw173

In healthy hearts, ventricular gap junctions are mainly composed by connexin43 (Cx43) and localize in the intercalated disc, enabling appropriate electrical coupling. In diseased hearts, Cx43 is heterogeneously down-regulated, whereas activity of calmodulin/calcium-calmodulin protein kinase II (CaM/CaMKII) signalling increases. It is unclear if CaM/CaMKII affects Cx43 expression/localization or impulse propagation. We analysed different models to assess this. AC3-I mice with CaMKII genetically inhibited were subjected to pressure overload (16 weeks, TAC vs. sham). Optical and epicardial mapping was performed on Langendorff-perfused rabbit and AC3-I hearts, respectively. Cx43 subcellular distribution from rabbit/mouse ventricles was evaluated by immunoblot after Triton X-100-based fractionation. In mice with constitutively reduced CaMKII activity (AC3-I), conduction velocity (CV) was augmented (n = 11, P < 0.01 vs. WT); in AC3-I, CV was preserved after TAC, in contrast to a reduction seen in TAC-WT mice (-20%). Cx43 expression was preserved after TAC in AC3-I mice, though arrhythmias and fibrosis were still present. In rabbits, W7 (CaM inhibitor, 10 µM) increased CV (6-13%, n= 6, P< 0.05), while susceptibility to arrhythmias decreased. Immunoconfocal microscopy revealed enlarged Cx43 cluster sizes at intercalated discs of those hearts. Total Cx43 did not change by W7 (n= 4), whereas Triton X-100 insoluble Cx43 increased (+21%, n= 4, P< 0.01). Similar findings were obtained in AC3-I mouse hearts when compared with control, and in cultured dog cardiomyocytes. Functional implication was shown through increased intercellular coupling in cultured neonatal rat cardiomyocytes. Both acute and chronic CaM/CaMKII inhibition improves conduction characteristics and enhances localization of Cx43 in the intercalated disc. In the absence of fibrosis, this reduced the susceptibility for arrhythmias.